Pancreatic Cancer Research

ResearcherQueen Mary University of LondonActive in the last 2 years

Oleg B. Blyuss

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0194-6389; OpenAlex author ID A5038382199. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 4 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 1 paper

Papers 11

  1. Graph Neural Network Modelling of Pre-Diagnostic Serum Proteomics for Pancreatic Cancer Detection. Last author DOI 10.3390/diagnostics16203283↗
  2. A Clinical Laboratory Improvement Amendments/College of American Pathologists-Compliant Noninvasive Laboratory-Developed Test for Early Detection of Pancreatic… Co-author DOI 10.1016/j.jmoldx.2024.10.001↗
  3. Plasma vascular endothelial growth factor levels are a potential therapy-response biomarker for pancreatic cancer. First author DOI 10.3389/fonc.2025.1672385↗
  4. Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection. Co-author DOI 10.1371/journal.pcbi.1012408↗
  5. Evaluation of urinary C-reactive protein as an early detection biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2024.1450326↗
  6. Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis. First author DOI 10.1002/ijc.34287↗
  7. Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients. Co-author DOI 10.1038/s41416-019-0694-0↗
  8. Response to the comment on “Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients” Co-author DOI 10.1038/s41416-020-1014-4↗
  9. Urine metallomics signature as an indicator of pancreatic cancer. Co-author DOI 10.1039/d0mt00061b↗
  10. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study. Co-author DOI 10.1371/journal.pmed.1003489↗
  11. Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection. Co-author DOI 10.1158/1078-0432.ccr-14-0365↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tatjana Crnogorac‐Jurcevic · 7 shared papers, 2020–2025 · strength 1.21
  2. Silvana Debernardi · 4 shared papers, 2020–2025 · strength 0.73
  3. Alexey A. Zaikin · 4 shared papers, 2015–2026 · strength 0.66
  4. Hemant Mahendrakumar Kocher · 3 shared papers, 2020–2025 · strength 0.64
  5. Stephen P. Pereira · 4 shared papers, 2015–2024 · strength 0.52
  6. Jian Tajbakhsh · 2 shared papers, 2024–2025 · strength 0.46
  7. Stephen Jacob Pandol · 2 shared papers, 2024–2025 · strength 0.46
  8. Nirdesh K. Gupta · 2 shared papers, 2024–2025 · strength 0.46
  9. Christine Hughes · 1 shared paper, 2025 · strength 0.42
  10. Eithne Costello · 3 shared papers, 2015–2024 · strength 0.32
  11. Alexander Ney · 2 shared papers, 2020–2024 · strength 0.28
  12. Simon K. Lo · 1 shared paper, 2025 · strength 0.26
  13. Nurshad Ali · 1 shared paper, 2024 · strength 0.20
  14. Pilar Acedo · 1 shared paper, 2024 · strength 0.19
  15. Giuseppe Fusai · 1 shared paper, 2024 · strength 0.19
  16. Hui Cai · 1 shared paper, 2023 · strength 0.18
  17. Kirtiman Srivastava · 1 shared paper, 2023 · strength 0.18
  18. Christie Y. Jeon · 1 shared paper, 2023 · strength 0.18
  19. Xiao‐Ou Shu · 1 shared paper, 2023 · strength 0.18
  20. Qiuyin Cai · 1 shared paper, 2023 · strength 0.18
  21. Kathrin Schilling · 1 shared paper, 2020 · strength 0.12
  22. Núria Malats · 1 shared paper, 2020 · strength 0.09
  23. William Greenhalf · 1 shared paper, 2020 · strength 0.09
  24. Claire Jenkinson · 1 shared paper, 2015 · strength 0.04
  25. Ross C. Smith · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.